Joshua N. Liberman, PhD, MBA

Health Analytics, LLC, Columbia, Maryland; Corresponding Author: Joshua N. Liberman, PhD, MBA, Health Analytics, LLC, 6030 Daybreak Circle, Suite A150 #351, Clarksville, MD 21029 ([email protected]).

JCP
Barriers to Esketamine Nasal Spray Use in Treatment-Resistant Depression
Original Research

May 6, 2024

Potential barriers to treatment with esketamine nasal spray include travel distance, insurance, low socioeconomic status, and minority communities.
Kruti Joshi, Joshua N. Liberman, Purva Parab, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe